Navigation Links
The tranSMART Foundation Announces New Version of the tranSMART Open Source Data Sharing Platform for the Life Sciences Community
Date:9/16/2013

Wakefield, Mass. (PRWEB) September 16, 2013

The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share their pre-competitive data, today announced the release of tranSMART version 1.1. Originally developed as an internal project by Johnson & Johnson, this new version of the cloud-based data sharing solution eliminates the need for user organizations to purchase commercial software and integrates significant new contributions by the developer community over the past year into one new release.

“Scientists at universities, non-profit research organizations, and pharmaceutical and biotechnology companies are struggling to effectively leverage the massive amounts of high-quality research data available to advance their studies,” said tranSMART Foundation co-CEO Brian Athey, Ph.D., also with the University of Michigan. “To date, we have more than 25 life science organizations utilizing the tranSMART platform to link research data with clinical data in a central repository. We envision that through this platform scientists will have the ability to effectively collaborate using pre-competitive data – facilitating quicker and more cost-effective translational medicine research.”

The Foundation’s co-CEO, Michael Braxenthaler, Ph.D., who also holds positions with Roche and the Pistoia Alliance, added, “Our goal is to create a collaborative translational research community. Our development community is focused on the Foundation’s three C’s: code, community and content. With the open tranSMART platform, we are limiting dependency on commercial software products and leveraging the expertise of the entire user community. We have an aggressive product roadmap to develop the next generation of the platform to include new interfaces and analytical functionality as well as a more modern information architecture.”    

The tranSMART Foundation is a partnership between the Pistoia Alliance, the University of Michigan and the Imperial College London with the mission to enable effective sharing, integration, standardization, and analysis of heterogeneous data from collaborative translational research by mobilizing the tranSMART open-source and open-data community.

As an open source solution, several leading U.S. and European-based academic, pharmaceutical and service provider organizations have contributed to this release through code development, quality assurance, testing, scientific data contribution, and hosting services for “demo” instances.

Please visit: http://www.transmartfoundation.org/site/tm-r11-splash for access to release notes, documentation, source code, and other resources. Training and support for the user community is provided by the tranSMART Foundation, as well its network of service providers.    

About The tranSMART Foundation
The tranSMART Foundation is a non-profit organization that provides an open-source, cloud-based, data-sharing and analysis platform that enables scientists at universities, disease foundations, pharmaceutical companies, and government agencies around the world to share pre-competitive data in a way that saves money and time in translating research findings into new therapies and diagnostic tools. Founded to steward the tranSMART platform, the Foundation is led by the Pistoia Alliance, University of Michigan and Imperial College London. Headquartered in Wakefield, Massachusetts and with Centers of Excellence in Ann Arbor, Mich.; London, England; Boston, Mass.; and Amsterdam, Netherlands, the tranSMART Foundation can also be found on the web at http://www.tranSMARTFoundation.org.

###

Read the full story at http://www.prweb.com/releases/2013/9/prweb11123518.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Thomson Reuters to Host tranSMART Community Meeting During BIO-IT World Conference
2. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
3. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
4. Leaders in Science Join Upcoming Celebration of the 100th Anniversary of the Oldest Science Foundation in America
5. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
6. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
7. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
8. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
9. Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial
10. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
11. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
Breaking Biology Technology:
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
Breaking Biology News(10 mins):